Dizal (jiangsu) Pharmaceutical Co. Ltd. Class ASSE: 688192

Announcement on Expected Loss in Performance for 2025

· Issued by Dizal (jiangsu) Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Expected Loss in Performance for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment